Bacterium Blocks Antibiotic Entry Using Small Protein
University of Geneva researchers found how Pseudomonas aeruginosa restricts entry of the critical-care antibiotic imipenem.
Updated on Nov. 19, 2026 in Life Sciences

Researchers at the University of Geneva have discovered how the hospital-acquired bacterium Pseudomonas aeruginosa limits entry of the antibiotic imipenem. The findings were published in the Proceedings of the National Academy of Sciences.
Why it matters
Pseudomonas aeruginosa is responsible for many hospital-acquired infections, and imipenem is reserved for the most critical cases, so resistance mechanisms directly affect treatment options. The findings open new avenues for eventually counteracting antibiotic resistance.
The study is a mechanistic laboratory investigation published in a peer-reviewed journal, but the extraction gives no quantitative measurements of imipenem entry or resistance levels. It remains unclear how broadly the PtrA mechanism applies beyond the bacterium and antibiotic studied.
The players
University of Geneva
A public research university in Geneva, Switzerland, known for its strong biomedical and life sciences research programs.
Proceedings of the National Academy of Sciences
A peer-reviewed scientific journal published by the U.S. National Academy of Sciences that publishes high-impact research across many scientific disciplines.
The details
When attacked by immune cells, the bacterium is exposed to high concentrations of copper and zinc, prompting it to gradually reduce production of OprD porins, the channel imipenem normally uses to enter. The small protein PtrA, produced in the presence of metals, inserts into the same protein complexes as OprD and blocks the channel entrance.
Timeline
November 19, 2026: Study published in the Proceedings of the National Academy of Sciences and article released.
The Big Picture
The findings extend the established understanding that reduced expression of OprD porins drives carbapenem resistance in Pseudomonas aeruginosa by identifying PtrA as a protein that actively blocks the remaining channel. This adds a mechanistic layer to how metal exposure during immune attack can shape antibiotic susceptibility.
Antibiotic resistance mechanisms like this one can determine whether infections in hospitals remain treatable, so future work on disabling PtrA could eventually help preserve the effectiveness of critical-care drugs. Researchers have not yet indicated when such approaches might reach clinical use.
The takeaway
Bacteria can shift their own defenses in response to threats from the immune system, which makes antibiotic resistance harder to predict. Understanding these internal switches may guide future strategies for keeping existing antibiotics effective.
Further reading
For related context on microbial biology, explore Life Sciences coverage on Wisevoter.
Source note: This article includes information reported by Phys.



